OKYO Pharma market cap: $69.798 M

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

#118Kalaris TherapeuticsKLRS$77.2M
#119Champions OncologyCSBR$73.2M
#120OKYO PharmaOKYO$69.8M
#121Eloxx PharmaceuticalsELOX$69.4M
#122Inmune BioINMB$63.6M

Insiders buying

6 open-market purchases by officers and directors of OKYO Pharma, worth $131.1K. Grants and option exercises are excluded.

Gabriele M. Cerrone$35.0K
25,000 shares at $1.40 on 20 Jul 2026 · filed 7 Aug 2026
Gabriele M. Cerrone$32.6K
22,500 shares at $1.45 on 21 Jul 2026 · filed 7 Aug 2026
Flavio MantelliCHIEF MEDICAL OFFICER$28.0K
20,000 shares at $1.40 on 21 Jul 2026 · filed 7 Aug 2026
Robert John DempseyCHIEF EXECUTIVE OFFICER$23.1K
15,000 shares at $1.54 on 22 Jul 2026 · filed 7 Aug 2026
John P. Brancaccio$7.38K
5,000 shares at $1.48 on 21 Jul 2026 · filed 7 Aug 2026
Rajkumar Patil VChief Scientific Officer$5.01K
3,363 shares at $1.49 on 27 Jul 2026 · filed 7 Aug 2026

What if OKYO Pharma were worth as much as…

Open the what-if tool →

Gold $30.3T

$576,873.61

Per share 433,740× higher

Bitcoin $1.72T

$32,770.95

Per share 24,640× higher

Nvidia $5.48T

$104,418.97

Per share 78,511× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for OKYO Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.